Researchers at Harvard Medical School developed PDGrapher, an AI model that predicts gene targets capable of reverting diseased cells to healthy states by analyzing multiple disease drivers simultaneously. This combinatorial prediction approach surpasses traditional single-target drug discovery, potentially accelerating therapeutic design and unlocking treatments for complex diseases involving multiple pathways. PDGrapher is freely available to aid drug development.